Patents by Inventor Myoung Suk Choi

Myoung Suk Choi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9562227
    Abstract: The present invention relates to a method for screening anticancer agent or SIP1/ZEB2 inhibitor using integrin alpha 5 (ITGA5), more precisely a method for measuring integrin alpha 5 expression pattern in SIP1/ZEB2 over-expressing cell line or SIP1/ZEB2 expression induced cell line, both treated with sample compounds, by comparing with that of the control. The method of the present invention facilitates screening of anticancer agent or SIP1/ZEB2 inhibitor simply by measuring integrin alpha 5 expression, so that it can be effectively applied in the field of medicine.
    Type: Grant
    Filed: December 5, 2008
    Date of Patent: February 7, 2017
    Assignee: Korea Research Institute of Bioscience & Biotechnology
    Inventors: Semi Kim, Hee Young Kang, Myoung Suk Choi, Mi-Ra Lee, Jin-San Yoo, Young Kyu Park
  • Publication number: 20120201838
    Abstract: The present invention relates to a method for screening anticancer agent or SIP1/ZEB2 inhibitor using integrin alpha 5 (ITGA5), more precisely a method for measuring integrin alpha 5 expression pattern in SIP1/ZEB2 over-expressing cell line or SIP1/ZEB2 expression induced cell line, both treated with sample compounds, by comparing with that of the control. The method of the present invention facilitates screening of anticancer agent or SIP1/ZEB2 inhibitor simply by measuring integrin alpha 5 expression, so that it can be effectively applied in the field of medicine.
    Type: Application
    Filed: December 5, 2008
    Publication date: August 9, 2012
    Applicant: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Semi Kim, Hee Young Kang, Myoung Suk Choi, Mi-Ra Lee, Jin-San Yoo, Young Kyu Park